Dublin, July 29, 2020 (GLOBE NEWSWIRE) -- The "Global Female Technology (Femtech) Market: Analysis and Forecast, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

Market Overview

Despite having huge potential, the Femtech industry is still immensely underfunded accounting for only 1.4% aggregated capital that flows into healthcare. Also, a large number of healthcare venture capitalists are yet to invest in this sector. Indeed, the amount of investment received by the Femtech industry is on a rise but at a surprisingly slow pace considering the potential of the market.

However, the signs of future growth are also quite evident. Five years ago, the amount of funding received by this sector had barely reached about $100 million. The Femtech industry witnessed more than $500 million in funding (until 2019). The number of women-centric start-ups has significantly multiplied in recent years. This surge is also primarily attributed to the launch of the fertility tracking app by PayPal co-founder Max Levchin in 2013. The app also witnessed high profile VC funding from agencies such as Andreessen Horowitz and Founders Fund.

Today, a large number of start-ups could be seen in the market offering fertility tracking apps, as well as those focused on egg freezing and fertility treatments, women-centric clinical care, and even subscription-based tampons. Some of the top-tier VCs have also entered this field. For example, Kleiner Perkins, has backed a fertility platform called Progyny with a funding of $49 million, while NEA has backed a sexual wellness start-up called Nuelle offering financial support of $23 million.

As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double-digit CAGR of 12.65% during the forecast period. One of the major driving factors for the market is the increasing incidence of infectious and chronic diseases among the female population leading to a surge in demand for effective and more personalized treatment. Furthermore, women's health awareness has significantly increased in recent years. For instance, it was not until 2004, the cardiovascular diseases were considered medically a threat to women's health. However, campaigns such as the American Heart Association's Go Red for Women campaign and the NHLBI's Heart Truth program have significantly boosted the awareness related to life-threatening diseases such as CVD.

Another reason driving the growth of the market is the growing prevalence of infectious disease among females in low to middle-income countries due to an unhygienic environment. For instance, in 2013, 60% of new HIV infections in the population younger than 25 years occurred in girls and young women. Also, untreated syphilis in low- and middle-income countries still causes over 200000 deaths every year.

However, some of the major challenges restraining the growth of the market are: creation of awareness among women, particularly in rural areas, unequal distribution of women as compared to men in investment community, and lack of understanding of women's health issues by investors, among others.

Competitive Landscape

The Femtech market comprises over 200 start-ups worldwide, 92 percent of which are founded and led by women. Big names in these areas are developing entirely new solutions such as the Flex Disc, Thinx absorbent period underwear, or the Glow fertility and ovulation tracker. While others focus on building tech platforms and subscription services to make existing products such as birth control and period products more easily accessible.

Although the majority of Femtech firms are focusing on the millennials, there are also companies working for women at all ages. For example, Genneve, an online clinic aimed at aiding women entering menopause. Also, other companies such as Madorra and MenoGeni are developing devices and pharmaceutical alternatives to aid in the treatment of menopausal symptoms. Companies are extensively entering new women's health spaces to stand out in the competition. Some of the emerging women's health spaces are osteoporosis, breast cancer, autoimmune conditions, stroke, thyroid issues, chronic fatigue, anxiety, and depression.

Research Highlights:

• The services segment is expected to grow at the highest CAGR of 15.58 percent during the forecast period. The growth in this segment is primarily due to the emergence of a plethora of start-ups catering to fertility management and support services, egg retrieval and egg freezing services, among many associated services. Some of the companies include Kindbody, Modern Fertility, and Prelude Fertility.
• Apps such as pregnancy and fertility tracking apps form the major component of the femtech market currently accounting for an estimated 62.28% of the entire femtech market. The apps segment is expected to reach a value of $1.78 billion by the end of 2030, growing at a CAGR of 12.05%, during the forecast period.
• As of 2019, reproductive health is the largest area of application for the femtech market. The segment accounts for an estimated 56.13% of the overall market. There are a plethora of apps for tracking periods and the menstrual cycle, such as Clue and Flo.
• From an end user perspective, individuals women account for an estimated 66.09% of the overall market. However, during the forecast period, fertility clinics followed by hospitals are expected to grow at the highest CAGRs of 13.38% and 13.31%, respectively. The growth from the fertility clinics is anticipated considering the huge funding of start-ups providing fertility-related services such as IVF and IUI to get pregnant, or for egg preservation.
  

Key questions answered in the report:

• How Femtech products are positioned to save billions of dollars of women's healthcare expenditure annually?
• What are the leading end user groups of Femtech products and services?
• How funding dynamics in the global Femtech market will change during the forecast period?
• What are the major developments such as product launches, mergers and acquisitions, collaborations, and partnerships taking place in the market and how are they changing the overall dynamics of the Femtech market?
• What are the major areas of Women's health, the key market participants are catering to?
• What are the major pricing/business model strategies employed by the market players that can significantly put a pricing pressure on other competitors?
• What is the installed base or adoption rate for Femtech solutions in the market?
• What are the technological and regional trends pertaining to the global Femtech market?
• What is the growth potential of the global Femtech market in North America, Europe, Asia-Pacific, Latin America and Rest-of-the-World?

Key Topics Covered:

Executive Summary

1 Product Definition
1.1 Inclusion and Exclusion

2 Scope of the Study
2.1 Key Questions Answered in the Report

3 Research Methodology
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Market Estimation Model
3.4 Companies Profiled
3.5 Assumptions and Limitations

4 Industry Analysis
4.1 Industry Trends
4.2 Femtech Innovation Tracker
4.3 Regulatory Framework
4.4 Funding Analysis

5 Competitive Landscape
5.1 Key Developments and Strategies
5.2 Business Model Analysis
5.3 Product Mapping Analysis

6 Market Dynamics
6.1 Market Drivers
6.2 Market Restraints
6.3 Market Opportunities

7 Global Femtech Market
7.1 Assumptions and Limitations
7.2 Key Findings and Opportunity Assessment
7.2.1 Key Findings
7.2.2 Opportunity Assessment

8 Global Femtech Market (by Component)
8.1 Overview
8.2 Mobile Apps
8.3 Connected Devices
8.4 Services
8.5 Others (Organic, Smart Female Hygiene Products)

9 Global Femtech Market (by Application)
9.1 Overview
9.2 Reproductive Health
9.3 General Wellness
9.4 Pregnancy and Nursing Care
9.5 Pelvic and Uterine Care

10 Global Femtech Market (by End User)
10.1 Overview
10.2 Individuals
10.3 Fertility Clinics
10.4 Hospitals and Research Institutes
10.5 Diagnostic Centers

11 Global Femtech Market (By Region)
11.1 Overview
11.2 North America
11.3 Europe
11.4 Asia-Pacific
11.5 Middle East, South Africa, and Latin America

12 Company Profiles
12.1 Overview
12.2 ALYK, Inc.
12.3 Aytu BioScience, Inc.
12.4 Biowink GmbH
12.5 Bloomlife
12.6 CORA
12.7 Flo Health, Inc.
12.8 Glow, Inc.
12.9 Inne
12.10 Kasha
12.11 NaturalCycles Nordic AB
12.12 Ovia Health
12.13 Plackal Tech
12.14 Sustain Natural
12.15 The Flex Company
12.16 Thinx, Inc.
12.17 Company Snapshots
12.17.1 Celmatix Inc.
12.17.2 Conceivable Inc.
12.17.3 Lia Diagnostics Inc.
12.17.4 Lucina Health, Inc. (Subsidiary of Unified Women's Healthcare, LLC)
12.17.5 Progny, Inc.
12.17.6 Univfy Inc.

For more information about this report visit https://www.researchandmarkets.com/r/1jvpv2